— Know what they know.
Not Investment Advice

ELUT NASDAQ

Elutia Inc
1W: -5.0% 1M: -7.9% 3M: -17.8% YTD: +21.1% 1Y: -12.0% 3Y: -39.2% 5Y: -89.9%
$0.78
-0.02 (-2.66%)
 
Weekly Expected Move ±6.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $34.4M mcap · 35M float · 0.205% daily turnover · Short 33% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$12M -49.6% ▼
5Y CAGR: -22.0%
Gross Profit
$7M -38.4% ▼
5Y CAGR: -20.3%
Operating Income
-$18M +48.4% ▲
Net Income
$53M +198.9% ▲
EPS (Diluted)
$-0.79 +57.5% ▲
EBITDA
-$17M +62.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$47M$24M$25M$24M$12M
YoY Growth+11.0%-49.7%+3.8%-1.5%-49.6%
Cost of Revenue$28M$12M$14M$14M$6M
Gross Profit$19M$12M$11M$11M$7M
Gross Margin40.1%48.8%44.7%43.9%53.7%
R&D Expenses$9M$8M$4M$4M$4M
SG&A Expenses$33M$34M$27M$31M$21M
Operating Expenses$42M$47M$42M$46M$25M
Operating Income-$23M-$35M-$31M-$36M-$18M
Operating Margin-48.6%-147.5%-123.4%-146.3%-149.8%
Interest Expense$5M$5M$6M$5M-$387K
Income Before Tax-$25M-$36M-$41M-$54M-$16M
Tax Expense$55K$34K$28K$7K$13K
Net Income-$25M-$33M-$38M-$54M$53M
Net Margin-52.4%-137.9%-152.2%-221.3%434.2%
EPS (Diluted)$-2.38$-2.38$-2.07$-1.86$-0.79
EBITDA-$16M-$27M-$32M-$46M-$17M
Shares Outstanding10M14M18M29M46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms